With a $35.3 billion market value, Baxter International Inc (NYSE:BAX) ranks in the top 10% of its industry group, Health Care Equipment & Supplies, and in the top decile of sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's current Portfolio Grader score places it 5 among the 164 companies in this industry group, putting it in the top decile; among the sector leaders with a ranking of 11 among the 785 companies in the sector, and number 94 in the nearly 5,000 company Portfolio Grader universe.
Portfolio Grader currently ranks BAX as a Strong Buy. The system for fundamental and quantitative metrics used in this stock evaluation tool developed by Louis Navellier, assesses and ranks approximately 5,000 stocks each week. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.
Portfolio Grader currently ranks the Health Care sector number 10 among the 12 sectors in its universe putting it in the bottom quartile of all the GICS sectors. The Health Care Equipment & Supplies industry group is ranked 40 among the 69 industry groups within the GICS sectors, placing it below-average in terms of the Navellier scoring system.
BAX has attained well above-average scores in 3, and above-average scores in 3 of the 8 fundamental metrics used by Portfolio Grader in the ranking of company stocks.
BAX's operational scores provide mixed results with rankings for operating margin and earnings growth that are well above average, while the score for sales growth is below average. Scores for visibility of earnings are superior with a ranking for earnings revisions, earnings surprises and earnings momentum that are discernibly better than average. BAX's metric for return on equity is discernibly better than its industry group average but its ranking for cash flow is below-average. Baxter International's fundamental scores give BAX a place in the top decile of the industry group.
Portfolio Grader uses the Navellier Proprietary Quantitative Score to gauge BAX's shares from the perspective of risk/reward. This exclusive scoring system takes into account the relative value of the company's shares based on the current price of the shares relative to its peers, the market and risk associated with its industry and sector groups. Based on this risk/reward calculation, BAX currently scores well above-average in its industry group compared to its peers.
Louis Navellier's proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results, with A being 'strong buy' and F being 'strong sell'. Explore the tool here.
Commentary provided by UpTick Data Technologies.
